Data / Form D filings / Bioceptive, Inc.
Bioceptive, Inc.: Form D filings
Bioceptive, Inc., a biotechnology company in New Orleans, LA, filed 7 Form D notices with the SEC between 2011 and 2016. The latest, on January 29, 2016, reports $416,450 sold of a $650,000 offering to 16 investors.
Find out what Bioceptive, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- NEW ORLEANS BIOINNOVATION CENTER, 1441 CANAL STREET, SUITE 228, New Orleans, LA, 70112
- Phone
- (504) 598-5233
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2011
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1527900
The full lists. Form D filings in Louisiana: 144 rows, $7.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 29, 2016 | New notice | $650,000 | $416,450 | $233,550 | 16 | Jan 18, 2016 | sec.gov |
| Dec 30, 2013 | New notice | $1,500,000 | $1,250,000 | $250,000 | 12 | Dec 20, 2013 | sec.gov |
| Mar 1, 2013 | Amendment | $1,100,000 | $1,063,610 | $36,390 | 0 | Oct 25, 2012 | sec.gov |
| Oct 24, 2012 | New notice | $1,000,000 | $0 | $1,000,000 | 0 | Yet to occur | sec.gov |
| Mar 26, 2012 | Amendment | $250,000 | $40,000 | $210,000 | 2 | Mar 12, 2012 | sec.gov |
| Mar 26, 2012 | New notice | $200,000 | $40,000 | $160,000 | 2 | Mar 12, 2012 | sec.gov |
| Aug 15, 2011 | New notice | $135,000 | $135,000 | $0 | 3 | Aug 9, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joan Neuscheler | Director | |
| Joseph Kumar Lovett | Director | |
| Amit Kumar Rathi | Director | |
| Orin Levy | Director | |
| Shuchi Kumar Khurana | Executive Officer | |
| Benjamin Cappiello | Executive Officer, Director |
Other biotechnology companies in Louisiana that filed recently
- 28bio, Inc. $8.5 million · Oct 29, 2026
- Therapeutic Neuromodulation Systems LLC $1.7 million · Sep 21, 2026
Every Form D from the week of Jan 25, 2016 · All recent filings in Louisiana · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Bioceptive, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.